Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer

Oncologist

Volumn 1, Issue 3, 1996, Pages 140-150

  Abels, R I ^a   Larholt, Kay M ^a   Krantz, Kenneth D ^a   Bryant, Edward C ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Anemia; Cancer; Erythropoietin

Indexed keywords

EID: 0001390321     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.1-3-140     Document Type: Article

References (15)

1. Johnson R, Roodman G. Hematologic manifestations of malignancy. Disease-a-Month 1990;35:716-768.
2. Lee G. The anemia of chronic disease. Semin Hematol 1983;20:61-80.
3. Spivak J, Barnes D, Fuchs E et al. Serum immunoreactive erythropoietin in HTV-infected patients. JAMA 1989;261:3104-3107.
4. Baer A, Dessypris E, Goldwasser E et al. Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 1987;66:559-564.
5. Van Snik J, Masson P, Heremans J. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 1974;140:1068-1084.
6. Pincus T, Olsen W, Russell I et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-168.
7. Data on file. R. W. Johnson Pharmaceutical Research Institute, Raritan, NJ, USA.
8. Wood P, Njgaard S, Hrushesky W. Cisplatin-induced anemia is correctable with erythropoietin. Blood 1988;72(suppl 1):52a.
9. Miller C, Jones R, Piantadosi S et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-1692.
10. Platinol Product Label. Phys Desk Ref. Medical Economics, Inc., 1991:733-734.
11. Teehan B, Krantz S, Stone W et al. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kid Diseases 1991;28:50-59.
12. Fischl M, Galpin J, Levine J et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-1493.
13. Piroso E, Erslev A, Caro J. Inappropriate increase in erythropoietin titers during chemotherapy. Am J Hematol 1989;32:248-254.
14. Schapira L, Antin J, Ransil B et al. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990;76:2354-2358.
15. Miller C, Jones R, Bums W et al. Impaired erythropoietin (EPO) response after bone marrow transplantation. Exp Hematol 1990;18:700.